These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 27997683)

  • 21. Clinical Dutch-English Lambert-Eaton Myasthenic syndrome (LEMS) tumor association prediction score accurately predicts small-cell lung cancer in the LEMS.
    Titulaer MJ; Maddison P; Sont JK; Wirtz PW; Hilton-Jones D; Klooster R; Willcox N; Potman M; Sillevis Smitt PA; Kuks JB; Roep BO; Vincent A; van der Maarel SM; van Dijk JG; Lang B; Verschuuren JJ
    J Clin Oncol; 2011 Mar; 29(7):902-8. PubMed ID: 21245427
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lambert-Eaton myasthenic syndrome (LEMS). Clinical and electrodiagnostic features and response to therapy in 59 patients.
    Tim RW; Massey JM; Sanders DB
    Ann N Y Acad Sci; 1998 May; 841():823-6. PubMed ID: 9668336
    [No Abstract]   [Full Text] [Related]  

  • 23. IVIg in myasthenia gravis, Lambert Eaton myasthenic syndrome and inflammatory myopathies: current status.
    Illa I
    J Neurol; 2005 May; 252 Suppl 1():I14-8. PubMed ID: 15959667
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Therapy in myasthenia gravis and Lambert-Eaton myasthenic syndrome.
    Newsom-Davis J
    Semin Neurol; 2003 Jun; 23(2):191-8. PubMed ID: 12894384
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Amifampridine for the treatment of Lambert-Eaton myasthenic syndrome.
    Oh SJ
    Expert Rev Clin Immunol; 2019 Oct; 15(10):991-1007. PubMed ID: 31533480
    [No Abstract]   [Full Text] [Related]  

  • 26. Therapeutic approaches to Lambert-Eaton myasthenic syndrome in the intra-individual comparison.
    Jost WH; Mielke U; Schimrigk K
    Wien Klin Wochenschr; 1991; 103(20):629-32. PubMed ID: 1763511
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of intravenous immunoglobulin for treatment of Lambert-Eaton myasthenic syndrome without anti-presynaptic P/Q-type voltage-gated calcium channel antibodies: a case report.
    Okada A; Koike H; Nakamura T; Motomura M; Sobue G
    Neuromuscul Disord; 2015 Jan; 25(1):70-2. PubMed ID: 25444432
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Presynaptic Disorders: Lambert-Eaton Myasthenic Syndrome and Botulism.
    Gable KL; Massey JM
    Semin Neurol; 2015 Aug; 35(4):340-6. PubMed ID: 26502758
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 3,4-diaminopyridine for the treatment of Lambert-Eaton myasthenic syndrome.
    Wirtz PW; Titulaer MJ; Gerven JM; Verschuuren JJ
    Expert Rev Clin Immunol; 2010 Nov; 6(6):867-74. PubMed ID: 20979551
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Complete reversal of Lambert-Eaton myasthenic syndrome synaptic impairment by the combined use of a K+ channel blocker and a Ca2+ channel agonist.
    Tarr TB; Lacomis D; Reddel SW; Liang M; Valdomir G; Frasso M; Wipf P; Meriney SD
    J Physiol; 2014 Aug; 592(16):3687-96. PubMed ID: 25015919
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Presynaptic effects of immunoglobulin G from patients with Lambert-Eaton myasthenic syndrome: their neutralization by intravenous immunoglobulins.
    Buchwald B; Ahangari R; Weishaupt A; Toyka KV
    Muscle Nerve; 2005 Apr; 31(4):487-94. PubMed ID: 15685615
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Autoantibody against the presynaptic P/Q-type voltage-gated calcium channel in Lambert-Eaton myasthenic syndrome].
    Sakai W; Nakane S; Matsuo H
    Brain Nerve; 2013 Apr; 65(4):441-8. PubMed ID: 23568992
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term follow-up in infantile-onset lambert-eaton myasthenic syndrome.
    Portaro S; Parisi D; Polizzi A; Ruggieri M; Andreetta F; Bernasconi P; Toscano A; Rodolico C
    J Child Neurol; 2014 Sep; 29(9):NP58-61. PubMed ID: 24114606
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Myasthenia gravis and Lambert-Eaton myasthenic syndrome in the same patient.
    Sha SJ; Layzer RB
    Muscle Nerve; 2007 Jul; 36(1):115-7. PubMed ID: 17206662
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Favourable outcome after treatment with rituximab in a case of seronegative non-paraneoplastic Lambert-Eaton myasthenic syndrome].
    Boutin E; Rey C; Romeu M; Pouget J; Franques J
    Rev Med Interne; 2013 Aug; 34(8):493-6. PubMed ID: 23759215
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Lambert-Eaton myasthenic syndrome].
    Motomura M; Fukuda T
    Brain Nerve; 2011 Jul; 63(7):745-54. PubMed ID: 21747145
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 3,4-diaminopyridine base effectively treats the weakness of Lambert-Eaton myasthenia.
    Sanders DB; Juel VC; Harati Y; Smith AG; Peltier AC; Marburger T; Lou JS; Pascuzzi RM; Richman DP; Xie T; Demmel V; Jacobus LR; Aleš KL; Jacobus DP;
    Muscle Nerve; 2018 Apr; 57(4):561-568. PubMed ID: 29280483
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synaptic Pathophysiology and Treatment of Lambert-Eaton Myasthenic Syndrome.
    Tarr TB; Wipf P; Meriney SD
    Mol Neurobiol; 2015 Aug; 52(1):456-63. PubMed ID: 25195700
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relapse of both small cell lung cancer and Lambert-Eaton myasthenic syndrome after a 13-year disease-free survival period.
    Asano F; Watanabe K; Shinkai M; Tei Y; Mishina K; Tanabe M; Ishii H; Shinoda M; Shimokawaji T; Kudo M; Kaneko T
    Chin J Cancer; 2016 Jul; 35(1):63. PubMed ID: 27370896
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of intravenous immunoglobulin in Lambert-Eaton myasthenic syndrome with small-cell lung cancer: correlation with the titer of anti-voltage-gated calcium channel antibody.
    Takano H; Tanaka M; Koike R; Nagai H; Arakawa M; Tsuji S
    Muscle Nerve; 1994 Sep; 17(9):1073-5. PubMed ID: 8065398
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.